- Home
- NAMS vs KGS Comparison
NAMS vs KGS Comparison
Compare NAMS & KGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- KGS
- Stock Information
- Founded
- NAMS 2019
- KGS 2011
- Country
- NAMS Netherlands
- KGS United States
- Employees
- NAMS N/A
- KGS N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- KGS
- Sector
- NAMS Health Care
- KGS
- Exchange
- NAMS Nasdaq
- KGS Nasdaq
- Market Cap
- NAMS 2.7B
- KGS 3.2B
- IPO Year
- NAMS N/A
- KGS 2023
- Fundamental
- Price
- NAMS $27.00
- KGS $35.33
- Analyst Decision
- NAMS Strong Buy
- KGS Strong Buy
- Analyst Count
- NAMS 10
- KGS 9
- Target Price
- NAMS $41.40
- KGS $42.56
- AVG Volume (30 Days)
- NAMS 872.1K
- KGS 1.3M
- Earning Date
- NAMS 08-06-2025
- KGS 11-05-2025
- Dividend Yield
- NAMS N/A
- KGS 5.12%
- EPS Growth
- NAMS N/A
- KGS 53.07
- EPS
- NAMS N/A
- KGS 0.93
- Revenue
- NAMS $64,006,000.00
- KGS $1,286,651,000.00
- Revenue This Year
- NAMS N/A
- KGS $15.67
- Revenue Next Year
- NAMS N/A
- KGS $5.74
- P/E Ratio
- NAMS N/A
- KGS $37.69
- Revenue Growth
- NAMS 762.15
- KGS 31.01
- 52 Week Low
- NAMS $14.06
- KGS $25.21
- 52 Week High
- NAMS $27.29
- KGS $50.43
- Technical
- Relative Strength Index (RSI)
- NAMS 67.63
- KGS 53.98
- Support Level
- NAMS $24.41
- KGS $35.15
- Resistance Level
- NAMS $25.65
- KGS $36.25
- Average True Range (ATR)
- NAMS 1.10
- KGS 1.06
- MACD
- NAMS 0.05
- KGS -0.03
- Stochastic Oscillator
- NAMS 98.63
- KGS 42.55
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About KGS Kodiak Gas Services Inc.
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. It manages business through two operating segments namely Contract Services and Other Services. Contract Services consists of operating Company-owned and customer-owned compression, and gas treating and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings.